Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial.
about
The clinical efficacy of artemether/lumefantrine (Coartem)Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malariaArtemisinin-based combination therapy for treating uncomplicated malariaThe safety of amodiaquine use in pregnant womenUtilization of insecticide-treated nets by under-five children in Nigeria: assessing progress towards the Abuja targets.Dynamic RNA profiling in Plasmodium falciparum synchronized blood stages exposed to lethal doses of artesunate.Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.Malaria: an update on current chemotherapy.Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic reviewPerceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study.Therapeutic efficacies of artemisinin-based combination therapies in Nigerian children with uncomplicated falciparum malaria during five years of adoption as first-line treatments.Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia.Knowledge, Attitudes, and Practices about Malaria and Its Control in Rural Northwest Tanzania.Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial.Multiple treatment comparisons in a series of anti-malarial trials with an ordinal primary outcome and repeated treatment evaluations.Artesunate Plus Amodiaquine (AS+AQ) Versus Artemether -Lumefantrine (AL) for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Sub-Saharan Africa-A Meta-AnalysisIs chloroquine better than artemisinin combination therapy as first line treatment in adult nigerians with uncomplicated malaria?-A cost effectiveness analysisOpen-label trial of three dosage regimens of fixed-dose combination of artemisinin and naphthoquine for treating uncomplicated falciparum malaria in Calabar, NigeriaEfficacy of amodiaquine in the treatment of uncomplicated falciparum malaria in young children of rural north-western Burkina Faso.A qualitative study of the feasibility and community perception on the effectiveness of artemether-lumefantrine use in the context of home management of malaria in south-west Nigeria.Artesunate-amodiaquine for the treatment of uncomplicated malaria.Evaluation of the efficacy and safety of artemether-lumefantrine in the treatment of acute uncomplicated Plasmodium falciparum malaria in Nigerian infants and children.A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children.Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysisArtemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria.Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes.Evaluation of the comparative efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine and artesunate-amodiaquine-chlorpheniramine (Artemoclo™) for the treatment of acute uncomplicated malaria in Nigerian children.Artemether-Soluplus Hot-Melt Extrudate Solid Dispersion Systems for Solubility and Dissolution Rate Enhancement with Amorphous State Characteristics.
P2860
Q21034141-7E674236-3978-4C18-9075-BE9A66C96B0FQ21143739-D2BE28B0-4151-4170-97DD-FFCDA7697544Q24241785-0D786C9D-EC81-40B5-B74B-4451A5CF86DDQ28255205-5E6E41A8-7137-45A6-A57A-ECB304391FBAQ30483617-6BA2992F-0DBE-4FD0-85E1-DA4EC031E591Q33360465-409F8F3F-EE2C-40F2-937C-97CCCFC459C7Q33635019-7A31308C-5C33-4974-95A3-141BAAB89BA9Q34433106-2A5C0834-A6AE-4432-9DB2-ED2AC08093F7Q35029488-A340A24A-0543-4C0A-9F90-DF7F9A36DFB9Q35030048-E7C7E945-DEBC-4163-AE8C-369E8157EF1CQ35031900-C7573A52-8924-468B-A5F8-EF9B382B78A7Q35052961-8CD93575-4342-42D2-8451-50134D306226Q35649120-9ABA78C5-24FC-47A9-A7C4-885312FD4DE0Q35746267-FEB8EF07-1DAE-4BA4-A9B9-936BCD1EB8FFQ35986306-C8EBBCB7-636F-419C-B463-9484CF0CA342Q36394490-516A41A4-0E50-4B7F-A0DB-36A4C6624F03Q36398146-10B2D9CE-871C-4BC5-B064-BFC239D690C6Q36398162-6926BE68-012E-4E54-9D77-36FF722C5A08Q36513276-498DD763-9651-4631-9D19-5FD9011FFA80Q36606690-661D00B4-7B2D-4056-BE64-D0E2279F9731Q36724458-D1D6091E-95D6-44FD-912C-EBBAE9294BD1Q36861619-76A02660-1507-482D-86E8-35CBB412942BQ37037149-22D1D02B-041B-4C7D-BBBF-4918DD4E6F46Q37059334-6FFAAEAB-AB35-4A6D-BB66-FCC336A56766Q37350167-15602258-F44C-4F13-ABEF-2C0B19E5D915Q37388596-99B4D91F-F0A9-4518-905A-4F6802606830Q37423034-F576FDB4-97A4-47E8-BFAD-7B2106757E5EQ40210481-051644EC-CE37-4029-A73E-4F6E2A1BC61CQ40335976-2925E8DC-85D3-4670-BCFB-BCD7E0E72114
P2860
Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Artemether-lumefantrine versus ...... : randomized controlled trial.
@ast
Artemether-lumefantrine versus ...... : randomized controlled trial.
@en
Artemether-lumefantrine versus ...... : randomized controlled trial.
@nl
type
label
Artemether-lumefantrine versus ...... : randomized controlled trial.
@ast
Artemether-lumefantrine versus ...... : randomized controlled trial.
@en
Artemether-lumefantrine versus ...... : randomized controlled trial.
@nl
prefLabel
Artemether-lumefantrine versus ...... : randomized controlled trial.
@ast
Artemether-lumefantrine versus ...... : randomized controlled trial.
@en
Artemether-lumefantrine versus ...... : randomized controlled trial.
@nl
P2093
P2860
P921
P356
P1433
P1476
Artemether-lumefantrine versus ...... : randomized controlled trial.
@en
P2093
Ambrose Alaribe
Angela Oyo-Ita
Chukwuemeka Nwachukwu
Donald Ordu
Emmanuel Ezedinachi
John Ekenjoku
Martin Meremikwu
Regina Ejemot
P2860
P2888
P356
10.1186/1475-2875-5-43
P577
2006-05-16T00:00:00Z
P5875
P6179
1006436641